Further, Lipocine Inc. (LPCN) has a beta value of 0.59, and an average true range (ATR) of 0.2. 36-week biopsy data are expected mid-2021. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The current price is about 69.49% off the estimated low and 464.97% off the forecast high, based on this estimate. Go to the ... 02/19 PayPal Stock Passes Mastercard and … View institutional ownership trends for Lipocine. According to . Since then, LPCN stock has increased by 252.5% and is now trading at $1.59. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. According to the market data, Lipocine Inc (LPCN) stock price is $1.97 and the 52 weeks low is $0.301, which means the Lipocine Inc stock price is up 333.06% in the last 12 months. Analyst Price Target on LPCN. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. One share of LPCN stock can currently be purchased for approximately $1.59. Their forecasts range from $3.00 to $3.00. LPCN -- USA Stock : USD 2.04 0.10 5.15% : Lipocine Stock Forecast is based on your current time horizon. The capital turnover (annual revenue relative to shareholder's equity) for LPCN is 0.01 -- better than merely 9.18% of US stocks. LPCN Stock Predictions. Earnings for Lipocine are expected to grow in the coming year, from ($0.37) to ($0.26) per share. Investors will be thrilled if LPCN’s share price rises to $3, which is the median consensus price. This is 4.86% more than the trading day before Friday, 5th Feb 2021. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy." MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Analyst Forecasts According to 2 analysts, the average rating for Lipocine stock is "Buy." Their forecasts range from $3.00 to $3.00. The average price target is $3.00 with a high forecast of $3.00 and a low forecast of $3.00. If you’re ready to start capitalizing on this massive boom, legendary crypto investor Matt McCall just released a new free report, “3 Cryptos to Beat Bitcoin.”. Lipocine Inc. (LPCN) projections and forecasts Should I buy or sell LPCN? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Lipocine Inc. (NASDAQ:LPCN) released its quarterly earnings results on Tuesday, November, 10th. In the past three months, Lipocine insiders have sold more of their company's stock than they have bought. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. View our full suite of financial calendars and market data tables, all for free. The high price target for LPCN is $3.00 and the low price target for LPCN is $3.00. Receive a free world-class investing education from MarketBeat. View our earnings forecast for Lipocine. I see a cup and handle Very nice risk / reward here. LIPOCINE INC stock prediction: up to 2.03 USD LPCN stock price prognosis STOCK. Analysts have given the company’s stock an average 52-week price target of $5.33, forecast between a low of $3 and high of $10. About the Lipocine, Inc. stock forecast. LPCN Stock Forecast. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The company's pipeline candidates also include LPCN 1111, an oral testosterone therapy product for once daily dosing that completed Phase 2b testing; LPCN 1148, an oral prodrug of bioidentical testosterone for the treatment of non-alcoholic steatohepatitis cirrhosis (NASH); LPCN 1107, an oral hydroxyprogesterone caproate product for the prevention of recurrent preterm birth; and LPCN 1144, an oral prodrug of bioidentical testosterone that is in Phase 2 Clinical trial for the treatment of NASH. Fundamental company data provided by Zacks Investment Research. Lipocine's management team includes the following people: Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video), "Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project… The cryptocurrency market is exploding in value right now… Bitcoin broke through $30,000…. Lipocine has received 281 “outperform” votes. Learn about financial terms, types of investments, trading strategies and more. Lipocine is headquartered at 675 ARAPEEN DRIVE SUITE 202, SALT LAKE CITY X1, 84108. 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lipocine in the last year. To hit the forecast high, the stock’s price needs a +405.05% upsurge from its current level, while the stock would need to tank 51.52% for it to hit the projected low. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. Learn more. According to analysts' consensus price target of $3.00, Lipocine has a forecasted upside of 88.7% from its current price of $1.59. LPCN Stock Forecast - Get a free LPCN stock predictions and find out whether you should buy or sell LPCN stock. I do this only for practicing. LPCN -- USA Stock USD 1.94 0.09 4.86% Lipocine stock price prediction is an act of determining the future value of Lipocine shares using few different conventional methods such as EPS estimation , analyst consensus, or fundamental intrinsic valuation . © 2020 Cable News Network. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Analyst projections state that LPCN is forecast to be at a low of $3 and a high of $10. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Only 10.50% of the stock of Lipocine is held by insiders. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. According to analyst projections, LPCN’s forecast low is $3 with $10 as the target high. A Warner Media Company. The specialty pharmaceutical company can be reached via phone at 801-994-7383 or via email at [email protected]. Learn more. Disclaimer. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Forecast for Wed 10 Feb 2021 price 1.55 LIPOCINE INC stock price forecast for further price development up to 2.39% (time horizon: 1 day) and price target of 2.03 USD. In the short term (2weeks), LPCN's stock price should outperform the market by 6.19% . Lipocine does not currently pay a dividend. Based on 2 analysts offering 12 month price targets for Lipocine in the last 3 months. Specifically, they have bought $0.00 in company stock and sold $136,062.00 in company stock. View all of LPCN's competitors. Want to see which stocks are moving? Find the latest Lipocine Inc. (LPCN) stock quote, history, news and other vital information to help you with your stock trading and investing. Lipocine has received 55.21% “outperform” votes from our community. Only 10.87% of the stock of Lipocine is held by institutions. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. Lipocine has a P/B Ratio of 6.36. You can opt out at any time. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Lipocine Inc Stock Price Forecast, "LPCN" Predictons for2021 During the day the stock fluctuated 5.56% from a day low at $1.62 to a day high of $1.71. Some companies that are related to Lipocine include BeyondSpring (BYSI), Magenta Therapeutics (MGTA), Neoleukin Therapeutics (NLTX), Crinetics Pharmaceuticals (CRNX), Affimed (AFMD), Spectrum Pharmaceuticals (SPPI), Akebia Therapeutics (AKBA), Viking Therapeutics (VKTX), Spero Therapeutics (SPRO), SIGA Technologies (SIGA), 89bio (ETNB), Homology Medicines (FIXX), Spruce Biosciences (SPRB), CorMedix (CRMD) and Aldeyra Therapeutics (ALDX). Do Not Sell My Information. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Start Your Risk-Free Trial Subscription Here, Warren Buffett again encourages investors to bet on America, Biden team readies wider economic package after virus relief, The Latest: U.S. FDA approves J&J single-shot vaccine, Fraud overwhelms pandemic-related unemployment programs, In oil-rich Iraq, a few women buck norms, take rig site jobs, The Latest: At 100, Captain Tom Moore honored at funeral, J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine, Cronos Stock Pulls Back After Earnings, It Might Be Time To Buy Some, Guardion Health Sciences Stock Needs to Give Investors More Than Survival, Wait For a Better Price Before Placing a Bet On Churchill Downs, 3 Small Cap Dividend Stocks with Growth Prospects, It’s Okay to Take the Over on DraftKings Stock, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, Lipocine to Present at Two Upcoming Investor Conferences, Form 8-K Lipocine Inc. For: Feb 18 - StreetInsider.com, Lipocine Closes Underwritten Public Offering Of Common Stock - Yahoo Finance, Lipocine Closes Underwritten Public Offering Of Common Stock, Form 8-K Lipocine Inc. For: Jan 26 - StreetInsider.com, Vir Biotechnology, AIkido Pharma leads healthcare gainers - Seeking Alpha, Lipocine Prices $25 Million Underwritten Public Offering Of Common Stock - Yahoo Finance, Lipocine Prices $25 Million Underwritten Public Offering Of Common Stock, Lipocine under pressure on launching underwritten public offering - Seeking Alpha, Lipocine Announces Launch Of Public Offering Of Common Stock - PRNewswire, Lipocine Announces Launch Of Public Offering Of Common Stock, LPCN: Lipocine’s LiFT Results: A Comparison with Peers, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily.